Figure 3. Secondary Outcome Results: Opioid Use During Telemedicine Mobile Treatment Unit Treatment.

Each dot represents the percentage of opioid-positive urine screens per individual patient averaged across their entire treatment period. Any opioid except buprenorphine or norbuprenorphine analyte was considered an opioid positive urine test. As calculated by using the slope for the regression line, the estimated percentages of opioid negative urine screens were 45.07% at 0 days, 56.72% at 7 days, 62.59% at 30 days, 70.25% at 60 days, and 77.91% at 90 days from enrollment. The solid line represents the regression line; dashed lines represent the 95% CI for the regression line.